New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
about
A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.
P2860
New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@en
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@nl
type
label
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@en
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@nl
prefLabel
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@en
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@nl
P2093
P2860
P356
P1476
New liposomal doxorubicin nano ...... on thermo and pH sensitivity.
@en
P2093
Behrouz Zandieh-Doulabi
Marco N Helder
Mohammad Hasan Sheikhha
Samira Naderinezhad
Tymour Forouzanfar
P2860
P304
P356
10.1111/CBDD.12953
P577
2017-01-25T00:00:00Z